Big news in the Diabetes Community’s tech space, as the FDA has granted what it dubs “breakthrough device designation” to a future closed loop system that combines a continuous glucose monitor with an ...
Currently, one closed-loop system, the Medtronic MiniMed 670G, is in commercial use in the United States, but randomized trials are needed to assess its efficacy and safety. 8 Such a system, which ...
The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results